Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome
Submitted: 17 May 2021
Accepted: 11 November 2021
Published: 7 February 2022
Accepted: 11 November 2021
Abstract Views: 5582
PDF: 565
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- V. Grosso, E. Boveri, L. Bogliolo, C. Montecucco, R. Caporali, Diffuse alveolar hemorrhage as a manifestation of Behçet disease , Reumatismo: Vol. 65 No. 3 (2013)
- E. Lubrano, R. Scarpa, Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs , Reumatismo: Vol. 64 No. 2 (2012)
- M.E. Tezcan, O. Temizkan, A. Ozderya, M. Melikoglu, K. Aydin, M. Sargin, S. Temizkan, Color Doppler analysis of female reproductive vasculature in Behçet’s disease , Reumatismo: Vol. 67 No. 3 (2015)
- M. Lorenzin, A. Ortolan, P. Frallonardo, S. Vio, C. Lacognata, F. Oliviero, L. Punzi, R. Ramonda, Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study , Reumatismo: Vol. 68 No. 2 (2016)
- S. D'Angelo, C. Palazzi, I. Olivieri, Psoriatic arthritis: treatment strategies using biologic agents , Reumatismo: Vol. 64 No. 2 (2012)
- K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid, Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients? , Reumatismo: Vol. 71 No. 4 (2019)
- M. Muñoz-Urbano, J. Sánchez-Bautista, A. Ramirez, D.C. Quintero-González, Y. Santamaria-Alza, A.L. Vanegas-García, Clinical profile of patients with lupus psychosis in a Colombian cohort , Reumatismo: Vol. 74 No. 2 (2022)
- S. Rinaldi, A. Doria, F. Vescovi, S. Corbanese, L. Iaccarino, S. Della Libera, G. Perini, P.F. Gambari, Quality of life in systemic lupus erythematosus , Reumatismo: Vol. 53 No. 2 (2001)
- S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi, Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome , Reumatismo: Vol. 62 No. 2 (2010)
- L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca, Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis , Reumatismo: Vol. 65 No. 4 (2013)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.